IPOs this week : Aug 5 - 9, 19 (wk 32)

IPOs expected to price during the week include:

• BioVie (OTCQB:BIVI) on August 6 
• InMode (INMD) on August 7. 

IPO lockup expirations:

• IPO share lockup expirations arrive on Alector (NASDAQ:ALEC) and ToughBuilt Industries (NASDAQ:TBLTU) on August 6, as well as 
• Gossamer Bio (NASDAQ:GOSS) and Harpoon Therapeutics (NASDAQ:HARP) on August 7. 

Earnings:
A number of recent IPO companies are due to report earnings including

• BioBie (OTCQB:BIVI), Farfetch (NYSE:FTCH), Sonos (NASDAQ:SONO), Eventbrite (NYSE:EB) and Revolve Group (NYSE:RVLV). 

Also bubbling right under the surface, Saudi Aramco (ARMCO) is reportedly restarting preparations to raise $100B by from selling a 5% stake. It could easily be the biggest IPO in history.

IPOs this week : March 4 - 8, 2019

Things are starting to get a little more interesting in the IPO market after a snail's pace for most of 2019. Lyft (LYFT) filed for its IPO, while Peloton (PTON) and Chinese coffee chain Luckin are both moving in that direction. Lyft is reportedly hoping to draw a valuation of between $20B and $25B.

IPOs expected to price
This week, IPO pricings are anticipated for

• Shockwave Medical (SWAV) on March 6 and 

• Futu (FHL) on March 7. 

IPO quiet period expirations

There are also quiet period expirations for

• Alector (NASDAQ:ALEC) on March 4 and 

• both Harpoon Therapeutics (NASDAQ:HARP) and Gossamer Bio (NASDAQ:GOSS) on March 5.

Gossamer Bio (GOSS) began trading on the Nasdaq on 8 February 2019

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.

Sector: Healthcare

• Industry: Biotechnology
• Full Time Employees: 144
• Founded by Faheem Hasnain and Sheila Gujrathi in 2015
• Headquartered in San Diego, California
• https://www.gossamerbio.com

Ticker: GOSS

Gossamer Bio opened for trading at $19 after pricing upsized 17.25 mln share IPO (from 14.375 mln shares) IPO at $16, in-line with expected range